Abbott filed an 8‑K (Item 9.01) on Mar 9, 2026 furnishing an indenture and note forms for debt: Floating…
Filed with the SEC on · Summarized by InvestorsBot
Abbott filed an 8‑K (Item 9.01) on Mar 9, 2026 furnishing an indenture and note forms for debt: Floating Rate due 2029; 3.70% (2029); 4.00% (2031); 4.30% (2033); 4.65% (2036); 4.75% (2038); 5.50% (2056); 5.60% (2066). Wachtell opinion included. 🧾 $ABT $EXAS #DebtOffering #M&A
No dollar amounts disclosed. Abbott says proceeds are expected to support the proposed acquisition of Exact Sciences; closing date/use of proceeds are forward‑looking and subject to risk — see Prospectus Supplement & 2025 10‑K. ⚠️ $ABT $EXAS #Investors #Risk
Notes span 2029–2066 with coupons from 3.70%–5.60% plus a 2029 floating note — indicates long‑term financing for the deal. Investors should review indenture/exhibits for covenants and interest‑rate exposure. 📈 $ABT #FixedIncome #M&A